dupilumab
regeneron,sanofi
['dupixent', 'dupilumab', '$sny', 'regeneron', '$regn']
$regn $sny regeneron highlights dupixent (dupilumab) late-breaking phase 3 data at the eadv 2022 congress; says data show significant improvements in signs and symptoms of prurigo nodularisearly three times as many dupixent p... 
Professional Day Trader, Swing Trader since 2013. My goal is to gain and share knowledge to everyone here. Let's make all those big bucks together.